STAT

Months after a sexual harassment scandal, OrbiMed’s banking another billion

Months after being rocked by sexual harassment allegations, biotech’s largest investment fund is in process of raising $1 billion from investors, its largest offering to date, while the founder who was at the center of the controversy remains a partner at the firm.

Legendary biotech financier Sam Isaly said late last year that he would retire following publication of a STAT investigation in which six former OrbiMed employees said he regularly sexually harassed the firm’s female employees, particularly executive assistants.

But recent filings with the Securities. The Wall Street firm and Isaly are in the process of negotiating his departure, but it’s unclear how long those talks might take.

You're reading a preview, sign up to read more.

More from STAT

STAT5 min readSociety
Opinion: Diagnostics Are Essential For Universal Health Coverage To Succeed
It's difficult to cure illness without first diagnosing it, making diagnostics as important as medicines and vaccines in delivering universal health care.
STAT3 min readSociety
A Smartphone App Could Help Diagnose Ear Infections More Accurately — And At Home
With a paper funnel and machine learning, a new smartphone app could help determine at home whether a child has an ear infection.
STAT4 min read
Pharma Is Making Progress Addressing Global Health, But It’s Still A Mixed Bag
Drug makers are taking steps to reach people on very low incomes, but access programs are for just a few diseases.